I wok in biopharmaceutical industry in early Research and Development focused on neurodegeneration. Before transitioning to my current position, I was a post-doctoral fellow with Dr. George Q. Daley, Dean of Harvard Medical School and Professor in the Stem Cell Program at Boston Children's Hospital. I was a graduate student, from 2009-2014, with Dr. Brian D. Strahl in the Department of Biochemistry and Biophysics at the University of North Carolina at Chapel Hill. I received my undergraduate degree in B.Sc Human Biology (Major: Biochemistry) from the All India Institute of Medical Sciences, New Delhi, India, and my  Masters in Life Sciences from the Jawaharlal Nehru University, New Delhi, India. 

Broadly speaking, my scientific interests encompass how cells receive, process, and respond to extrinsic and intrinsic signals. Of particular interest to me, is the fine-tuning of temporal and spatial control of gene expression and genome function through regulation of chromatin structure and function. I am interested in how chromatin structure is regulated by interactions (functional and molecular) between DNA and histone modifications, transcription factors, and signaling molecules to control cell fates and cell states. One could define this as 'epigenetics' (see relevant commentaries here and here). 

I have extensive expertise in studying fundamental molecular and cellular mechanisms, their dysfunction in diseases (e.g. cancer, cancer predisposition, autoimmunity, and neuro-inflammation), and novel strategies to target these mechanisms in disease conditions. In service of these goals, I use various model systems: human cell lines, induced pluripotent stem cells (iPS cells), mice, and primary patient-derived cells. Please see the publications section to get a flavor of my science. In addition to scientific R&D, I am interested in the business side of biopharma especially venture-backed company creation, venture capital, and business development.